Impact Partnership Wealth »

4d Molecular Therapeutics In shares owned by Impact Partnership Wealth

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Impact Partnership Wealth from 13F filings

Historical chart of Impact Partnership Wealth investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Impact Partnership Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Impact Partnership Wealth

Quarter filed Position value Share count Share price at filing
2025-09-30 $96k 11k 8.69
2023-06-30 $1.0k 57 18.07

More positions owned by Impact Partnership Wealth

Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust Portfolio S&p400 (SPMD)
Vanguard Index Fds Value Etf (VTV)
Ssga Active Tr Spdr Ssga Ig Pub (PRIV)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Growth Etf (VUG)
Spdr Gold Tr Gold Shs (GLD)
Spdr Series Trust Portfolio Sh Tsr (SPTS)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust Portfolio S&p600 (SPSM)
Spdr Series Trust Portfli Intrmdit (SPTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)

View all positions for Impact Partnership Wealth

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In